Viewing Study NCT06046794


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-27 @ 10:54 PM
Study NCT ID: NCT06046794
Status: RECRUITING
Last Update Posted: 2025-06-11
First Post: 2023-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
Sponsor: Institut Paoli-Calmettes
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module